 |
|
Deficiency in the Prothrombin Complex with Obscure Etiology
SEYMOUR PERRY, M.D.
AMA Arch Intern Med. 1960;105(6):921-928.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Prior to 1934, any male with a congenitally acquired bleeding disorder was promptly classified as a hemophiliac. Women were not allowed this distinction, but were merely called "bleeders." However, in 1934 there began a series of important observations which clarified the role of the prothrombin complex in the clotting mechanism and the importance of vitamin K and bishydroxycoumarin (Dicumarol). Quick and his co-workers opened up a new era in the study of coagulation by describing a simple quantitative test for the estimation of prothrombin.1 Thus, for the first time, it became possible to classify patients with the common cause of bleeding into two groups; (1) those involving defects in thromboplastin formation, and (2) those with defects in the prothrombin complex.
Tn 1941 Rhoads and Fitzhugh2 ushered in this new era when they reported a patient who had been called a hemophiliac for nine years, but the development of
. . . [Full Text PDF of this Article]
Author Affiliations
Los Angeles With the Technical Assistance of Mary Baker, B.A.
From the Department of Medicine, School of Medicine, University of California at Los Angeles, and the Hematology Research Laboratory, Wadsworth Hospital, Veterans Administration Medical Center, Los Angeles. This work was supported in part by the U.S. Public Health Service, under contract #H-1069, by a grant from Parke, Davis & Company, and by a grant from The Gladys Bowyer Foundation.
Footnotes
Submitted for publication Aug. 28, 1959.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
